GLTO
Price
$4.41
Change
-$0.04 (-0.90%)
Updated
Sep 26, 12:58 PM (EDT)
Capitalization
5.89M
LSBCF
Price
$0.73
Change
-$0.07 (-8.75%)
Updated
Sep 25 closing price
Capitalization
30.09M
Interact to see
Advertisement

GLTO vs LSBCF

Header iconGLTO vs LSBCF Comparison
Open Charts GLTO vs LSBCFBanner chart's image
Galecto
Price$4.41
Change-$0.04 (-0.90%)
Volume$107
Capitalization5.89M
LakeShore Biopharma
Price$0.73
Change-$0.07 (-8.75%)
Volume$12.05K
Capitalization30.09M
GLTO vs LSBCF Comparison Chart in %
Loading...
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLTO vs. LSBCF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLTO is a Buy and LSBCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (GLTO: $4.45 vs. LSBCF: $0.73)
Brand notoriety: GLTO and LSBCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLTO: 83% vs. LSBCF: 14%
Market capitalization -- GLTO: $5.89M vs. LSBCF: $30.09M
GLTO [@Biotechnology] is valued at $5.89M. LSBCF’s [@Biotechnology] market capitalization is $30.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLTO’s FA Score shows that 1 FA rating(s) are green whileLSBCF’s FA Score has 1 green FA rating(s).

  • GLTO’s FA Score: 1 green, 4 red.
  • LSBCF’s FA Score: 1 green, 4 red.
According to our system of comparison, GLTO is a better buy in the long-term than LSBCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLTO’s TA Score shows that 4 TA indicator(s) are bullish while LSBCF’s TA Score has 5 bullish TA indicator(s).

  • GLTO’s TA Score: 4 bullish, 5 bearish.
  • LSBCF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, LSBCF is a better buy in the short-term than GLTO.

Price Growth

GLTO (@Biotechnology) experienced а +55.05% price change this week, while LSBCF (@Biotechnology) price change was -7.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LSBCF($30.1M) has a higher market cap than GLTO($5.89M). GLTO YTD gains are higher at: -4.301 vs. LSBCF (-78.899).
GLTOLSBCFGLTO / LSBCF
Capitalization5.89M30.1M20%
EBITDA-16.94MN/A-
Gain YTD-4.301-78.8995%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash10.2MN/A-
Total Debt75KN/A-
TECHNICAL ANALYSIS
Technical Analysis
GLTOLSBCF
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
57%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
55%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 3 days ago
72%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
GLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LSBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVS6.610.13
+2.01%
Corvus Pharmaceuticals
SRL6.040.04
+0.67%
Scully Royalty Ltd
HRL24.41-0.30
-1.21%
Hormel Foods Corp
FRME38.96-0.57
-1.44%
First Merchants Corp
SISI6.02-0.30
-4.75%
Shineco Inc

GLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLTO has been loosely correlated with VIVS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GLTO jumps, then VIVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLTO
1D Price
Change %
GLTO100%
+4.46%
VIVS - GLTO
38%
Loosely correlated
-2.54%
SYRE - GLTO
36%
Loosely correlated
-8.18%
KPTI - GLTO
34%
Loosely correlated
-3.20%
NUVL - GLTO
33%
Poorly correlated
-2.54%
ACRV - GLTO
32%
Poorly correlated
-1.28%
More

LSBCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LSBCF has been loosely correlated with STTK. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LSBCF jumps, then STTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSBCF
1D Price
Change %
LSBCF100%
-8.74%
STTK - LSBCF
38%
Loosely correlated
-2.55%
BCTX - LSBCF
30%
Poorly correlated
+3.38%
GLTO - LSBCF
27%
Poorly correlated
+4.46%
PROK - LSBCF
26%
Poorly correlated
-3.68%
GNFT - LSBCF
23%
Poorly correlated
-2.64%
More